GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Common Stock

Oncimmune Holdings (LSE:ONC) Common Stock : £0.74 Mil (As of Aug. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Common Stock?

Oncimmune Holdings's quarterly common stock stayed the same from Aug. 2023 (£0.74 Mil) to Feb. 2024 (£0.74 Mil) and stayed the same from Feb. 2024 (£0.74 Mil) to Aug. 2024 (£0.74 Mil).

Oncimmune Holdings's annual common stock increased from May. 2022 (£0.70 Mil) to Aug. 2023 (£0.74 Mil) but then stayed the same from Aug. 2023 (£0.74 Mil) to Aug. 2024 (£0.74 Mil).


Oncimmune Holdings Common Stock Historical Data

The historical data trend for Oncimmune Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Common Stock Chart

Oncimmune Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 Aug23 Aug24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.69 0.70 0.74 0.74

Oncimmune Holdings Semi-Annual Data
Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24 Aug24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.74 0.74 0.74 0.74

Oncimmune Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Oncimmune Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacturing, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.